S100A9 and osteosarcoma: Chen et al. further investigated the underlying mechanisms and found that S100A9 inhibited osteosarcoma cell proliferation, migration, invasion, and cell cycle by suppressing the mitogen-activated protein kinase and nuclear factor kappa B signaling pathways [24].